We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 210,000...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 0.501002004008 | 9.98 | 10.915 | 9.74 | 187924 | 10.38045009 | CS |
4 | -1.46 | -12.7067014795 | 11.49 | 12.47 | 8.61 | 253683 | 10.2853344 | CS |
12 | -1.21 | -10.7651245552 | 11.24 | 12.92 | 8.61 | 311484 | 11.20679149 | CS |
26 | 0.6 | 6.36267232238 | 9.43 | 12.92 | 8.61 | 345600 | 10.71897798 | CS |
52 | 5.23 | 108.958333333 | 4.8 | 16.9 | 4.67 | 610037 | 11.16877803 | CS |
156 | 4.87 | 94.3798449612 | 5.16 | 16.9 | 2.36 | 306963 | 10.48827628 | CS |
260 | 1.5 | 17.5849941383 | 8.53 | 16.9 | 2.36 | 289276 | 10.44390645 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions